**Core Concept:** The question pertains to the pharmacological activity of antibiotics against Mycobacterium tuberculosis, the bacterium causing Tuberculosis (TB). Antibiotics are used to treat TB infections, and their potency depends on factors like bacterial growth rate and drug penetration into the infected tissues.

**Why the Correct Answer is Right:** Ethambutol (C choice) is a bacteriostatic drug that inhibits the growth of rapidly and slowly dividing Mycobacterium tuberculosis. It works by interfering with mycolic acid synthesis, an essential component of the mycobacterial cell wall. Ethambutol has a higher potency against slowly dividing bacilli compared to other options.

**Why Each Wrong Option is Incorrect:**

A. Streptomycin (D choice) is a bactericidal antibiotic that targets the 16S ribosomal RNA, leading to protein synthesis inhibition and bacterial cell death. It is effective against rapidly dividing bacilli, not slowly dividing ones.

B. Isoniazid (A choice) is another bactericidal antibiotic that targets the inositol monophosphate synthesis pathway, leading to ATP depletion and bacterial cell death. Like streptomycin, isoniazid is effective against rapidly dividing bacilli, not slowly dividing ones.

C. Ethionamide (C choice) is another bactericidal antibiotic that inhibits the inositol monophosphate pathway, similar to isoniazid. It is also effective against rapidly dividing bacilli, not slowly dividing ones.

**Clinical Pearl:** Understanding the pharmacological activity of antibiotics is crucial for selecting the appropriate drug regimen in TB treatment, considering the bacterial growth rate and drug penetration into infected tissues. This ensures optimal treatment outcomes and reduces drug resistance development.

**Correct Answer:** C choice (Ethambutol) is the most active against slowly dividing Mycobacterium tuberculosis, making it a vital component in TB treatment regimens targeting slowly growing bacilli and rapidly growing bacilli.